ARMEN GARO H 4

What Happened
Garo H. Armen — Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. — received 4,925 shares of Agenus common stock on June 12, 2026 as payment of salary (an award/acquisition). The shares were valued at $3.30 each (closing price) for a total reported value of $16,253. These shares were issued under the company's 2019 Equity Incentive plan and are fully vested on the date of issuance.

Key Details

• Transaction date: June 12, 2026; filing date: June 16, 2026 (appears to be filed after the typical 2-business-day Form 4 window).
• Shares received: 4,925 at $3.30 per share; total value reported: $16,253. ($3.30 is the June 12, 2026 closing price.)
• Ownership after transaction: The Form 4 does not state a consolidated total of shares beneficially owned after this issuance. The filing notes these shares are held in Dr. Armen's IRA accounts.
• Notable footnotes: (1) Salary paid in stock with Compensation Committee approval; (2) shares fully vested at issuance; (3) shares held in IRA; (4) Dr. Armen has additional related holdings — 23,950 shares held by a 2020 GRAT for which he is trustee and investment authority, and Pixie Partners holds 5,000 shares in which he has a partial pecuniary interest (he disclaims beneficial ownership to the extent of that partial interest).

Context
This was not an open-market purchase or sale but a conversion of salary into company stock — a routine form of compensation rather than an independent buy/sell decision. Because the shares are fully vested on issuance, there are no additional vesting conditions tied to this grant. The filing date suggests the Form 4 may have been submitted after the standard 2-business-day reporting window.